Clinical Trial Update: Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lapaquistat acetate co-administered with statins in hypercholesterolemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)
• Statins

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED